Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Unity Bancorp
UNTY
$608M
| $786K | ﹤0.01% |
19,305
| – | – |
|
2927
BRC Inc
BRCC
$255M
| $785K | ﹤0.01% |
375,723
+15,923
| +4% | +$40.6K |
|
|
ALMS
2928
Alumis Inc
ALMS
$3.54B
| $785K | ﹤0.01% |
127,854
+14,453
| +13% | +$84.1K |
|
2929
Nathan's Famous
NATH
$405M
| $783K | ﹤0.01% |
8,122
+17
| +0.2% | +$1.52K |
|
|
PSIX
2930
Power Solutions International
PSIX
$766M
| $782K | ﹤0.01% |
+30,945
| New | +$1.07M |
|
2931
loanDepot
LDI
$553M
| $780K | ﹤0.01% |
655,137
+618,153
| +1,671% | +$1M |
|
2932
ASP Isotopes
ASPI
$520M
| $776K | ﹤0.01% |
165,364
+7,138
| +5% | +$35.6K |
|
2933
Zentalis Pharmaceuticals
ZNTL
$357M
| $774K | ﹤0.01% |
486,499
-10,863
| -2% | -$23.4K |
|
2934
Alector
ALEC
$171M
| $768K | ﹤0.01% |
624,730
-18,726
| -3% | -$30.5K |
|
2935
Coherus Oncology
CHRS
$213M
| $767K | ﹤0.01% |
950,676
-26,181
| -3% | -$30.1K |
|
2936
RBB Bancorp
RBB
$457M
| $766K | ﹤0.01% |
46,442
+444
| +1% | +$8.08K |
|
2937
Taysha Gene Therapies
TSHA
$1.83B
| $761K | ﹤0.01% |
547,128
+72,871
| +15% | +$122K |
|
2938
C4 Therapeutics
CCCC
$406M
| $760K | ﹤0.01% |
474,843
-11,523
| -2% | -$34.4K |
|
|
REFI
2939
Chicago Atlantic Real Estate Finance
REFI
$255M
| $756K | ﹤0.01% |
51,395
+63
| +0.1% | +$981 |
|
|
LOVE
2940
LoveSac
LOVE
$265M
| $755K | ﹤0.01% |
41,514
-10
| -0% | -$219 |
|
|
PBPB
2941
DELISTED
Potbelly
PBPB
| $753K | ﹤0.01% |
79,145
+2,620
| +3% | +$29K |
|
2942
BayCom
BCML
$331M
| $753K | ﹤0.01% |
29,898
+1
| +0% | +$27 |
|
2943
Colony Bankcorp
CBAN
$469M
| $751K | ﹤0.01% |
46,512
+44
| +0.1% | +$723 |
|
2944
Tango Therapeutics
TNGX
$4.87B
| $751K | ﹤0.01% |
548,014
+34,585
| +7% | +$84.9K |
|
2945
Cooper-Standard Automotive
CPS
$517M
| $749K | ﹤0.01% |
48,887
-135,777
| -74% | -$2.03M |
|
|
OBE
2946
Obsidian Energy
OBE
$622M
| $746K | ﹤0.01% |
127,280
-29,499
| -19% | -$163K |
|
2947
Kodiak Sciences
KOD
$2.81B
| $739K | ﹤0.01% |
263,370
-6,284
| -2% | -$34.2K |
|
2948
First Bancorp
FNLC
$401M
| $731K | ﹤0.01% |
29,569
+687
| +2% | +$17.6K |
|
2949
Ponce Financial Group
PDLB
$491M
| $730K | ﹤0.01% |
57,621
| – | – |
|
2950
Virgin Galactic
SPCE
$380M
| $730K | ﹤0.01% |
240,831
+18,949
| +9% | +$83.1K |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.